CN1139383C - 用于借助细胞毒试剂治疗肿瘤过程的含异黄酮类的治疗组合物 - Google Patents

用于借助细胞毒试剂治疗肿瘤过程的含异黄酮类的治疗组合物 Download PDF

Info

Publication number
CN1139383C
CN1139383C CNB998095478A CN99809547A CN1139383C CN 1139383 C CN1139383 C CN 1139383C CN B998095478 A CNB998095478 A CN B998095478A CN 99809547 A CN99809547 A CN 99809547A CN 1139383 C CN1139383 C CN 1139383C
Authority
CN
China
Prior art keywords
intravenous injection
transfusion
day
osajin
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998095478A
Other languages
English (en)
Chinese (zh)
Other versions
CN1312712A (zh
Inventor
F
F·达罗
R·基斯
A·福里德曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of CN1312712A publication Critical patent/CN1312712A/zh
Application granted granted Critical
Publication of CN1139383C publication Critical patent/CN1139383C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
CNB998095478A 1998-07-15 1999-07-13 用于借助细胞毒试剂治疗肿瘤过程的含异黄酮类的治疗组合物 Expired - Fee Related CN1139383C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR98/09059 1998-07-15
FR9809059A FR2781154B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Publications (2)

Publication Number Publication Date
CN1312712A CN1312712A (zh) 2001-09-12
CN1139383C true CN1139383C (zh) 2004-02-25

Family

ID=9528649

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998095478A Expired - Fee Related CN1139383C (zh) 1998-07-15 1999-07-13 用于借助细胞毒试剂治疗肿瘤过程的含异黄酮类的治疗组合物

Country Status (11)

Country Link
EP (1) EP1096929A1 (ja)
JP (1) JP2002520357A (ja)
KR (1) KR20020006510A (ja)
CN (1) CN1139383C (ja)
AU (1) AU761417B2 (ja)
BR (1) BR9912817A (ja)
CA (1) CA2337256A1 (ja)
EA (1) EA200100141A1 (ja)
FR (1) FR2781154B1 (ja)
IL (1) IL140580A0 (ja)
WO (1) WO2000003707A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
AUPP260798A0 (en) 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
PL205635B1 (pl) * 2001-04-09 2010-05-31 Inst Farmaceutyczny Nowe pochodne genisteiny i zawierające je środki farmaceutyczne
DE60313754T2 (de) * 2002-03-06 2008-01-24 The Medical Research and Education Trust, San Diego Botanischer extrakt mit antikrebs-aktivität enthaltend isoliquiritigenin
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
CA2590048C (en) 2007-05-23 2013-07-16 Institut National De La Recherche Scientifique Cytosine nucleoside analogs and isoflavones and uses thereof
CN106265669A (zh) * 2016-08-04 2017-01-04 大连理工大学 大豆苷元与10‑羟基喜树碱的药物组合及其应用
CN113842387A (zh) * 2021-11-19 2021-12-28 大连理工大学盘锦产业技术研究院 10-羟基喜树碱与鹰嘴豆芽素a的药物组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (ja) * 1982-09-09 1994-03-09 理化学研究所 制癌剤
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
JP2829387B2 (ja) * 1996-09-13 1998-11-25 農林水産省四国農業試験場長 脂肪細胞における脂肪分解促進用組成物
GB9621757D0 (en) * 1996-10-18 1996-12-11 Ciba Geigy Ag Phenyl-substituted bicyclic heterocyclyl derivatives and their use
US5733926A (en) * 1996-12-13 1998-03-31 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions

Also Published As

Publication number Publication date
KR20020006510A (ko) 2002-01-19
AU761417B2 (en) 2003-06-05
WO2000003707A1 (fr) 2000-01-27
IL140580A0 (en) 2002-02-10
FR2781154B1 (fr) 2001-09-07
CN1312712A (zh) 2001-09-12
FR2781154A1 (fr) 2000-01-21
JP2002520357A (ja) 2002-07-09
AU4628299A (en) 2000-02-07
EP1096929A1 (fr) 2001-05-09
CA2337256A1 (en) 2000-01-27
EA200100141A1 (ru) 2001-06-25
BR9912817A (pt) 2001-05-08

Similar Documents

Publication Publication Date Title
CN1195740C (zh) 含2-喹啉酮的药物组合物
CN1027265C (zh) 水溶性喜树碱类似物的制备方法
CN1139383C (zh) 用于借助细胞毒试剂治疗肿瘤过程的含异黄酮类的治疗组合物
CN1249753A (zh) 抑制法呢基(Farnesyl)转移酶的经N-或C-键结的咪唑类取代的1,8-相并合的喹啉酮(quinolinone)衍生物类
CN1192149A (zh) 用酰化嘧啶核苷降低化疗剂和抗病毒剂的毒性的方法
CN1788086A (zh) 抗Smad7的反义寡核苷酸(ODN)及其在医药领域中的用途
CN1103431A (zh) 测定富集于肿瘤反兴性细胞中的淋巴结的方法
CN1018640B (zh) 碲化合物的制备方法
CN1180374A (zh) 一种制备未分化细胞的方法
CN1711266A (zh) 具有抗增殖活性的嘧啶并化合物(ⅱ)
CN1139384C (zh) 用于与细胞毒性剂治疗肿瘤的基于类黄酮的治疗组合物
CN1774265A (zh) 神经再生药
CN1711094A (zh) Src家族非受体酪氨酸激酶抑制剂和吉西他滨的组合产品
CN1263471A (zh) 含抗肿瘤药物和羟肟酸衍生物且具有抗肿瘤增强活性和/或副作用降低的药物组合物
CN1703229A (zh) 治疗前列腺和其他癌的组合物和方法
CN1812986A (zh) 呋咱并苯并咪唑类化合物
CN1547613A (zh) 评估施用自身或者其代谢中间物被ugt1a1酶代谢的化合物引起严重毒性的方法
CN1224388C (zh) Ap/amp的改良前药形式
CN86103330A (zh) 一种新型糖肽衍生物的制备方法
CN1711099A (zh) 具有抗肿瘤和抗毒活性的提取物
CN1649612A (zh) 细胞分化的诱导方法
CN1942189A (zh) 5,10-亚甲基四氢叶酸在癌症治疗中的用途
CN1617755A (zh) 法尼基蛋白转移酶抑制剂和其它抗肿瘤剂联合使用在制备抗癌症的药物中的应用
CN1809583A (zh) 抑制hif-1表达的反义寡核苷酸
CN1144586C (zh) 2-(1-羟乙基)-5-羟基萘并[2,3-b]呋喃-4,9-二酮和含该化合物的抗肿瘤剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee